# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-22-023584
Filing Date
2022-05-03
Accepted
2022-05-03 16:01:51
Documents
35
Period of Report
2022-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | ea159290-8k_lantern.htm iXBRL | 8-K | 29312
2 | PRESS RELEASE DATED MAY 3, 2022 ANNOUNCING FINANCIAL RESULTS FOR QUARTER ENDED M | ea159290ex99-1_lantern.htm | EX-99.1 | 45759
3 | PRESENTATION RELATING TO MAY 3, 2022 CONFERENCE CALL AND LIVE WEBINAR TO DISCUSS | ea159290ex99-2_lantern.htm | EX-99.2 | 33082
7 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 3340
8 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 77530
9 | GRAPHIC | ex99-2_002.jpg | GRAPHIC | 337792
10 | GRAPHIC | ex99-2_003.jpg | GRAPHIC | 89224
11 | GRAPHIC | ex99-2_004.jpg | GRAPHIC | 120031
12 | GRAPHIC | ex99-2_005.jpg | GRAPHIC | 151189
13 | GRAPHIC | ex99-2_006.jpg | GRAPHIC | 155532
14 | GRAPHIC | ex99-2_007.jpg | GRAPHIC | 136960
15 | GRAPHIC | ex99-2_008.jpg | GRAPHIC | 173457
16 | GRAPHIC | ex99-2_009.jpg | GRAPHIC | 127725
17 | GRAPHIC | ex99-2_010.jpg | GRAPHIC | 134888
18 | GRAPHIC | ex99-2_011.jpg | GRAPHIC | 187832
19 | GRAPHIC | ex99-2_012.jpg | GRAPHIC | 136921
20 | GRAPHIC | ex99-2_013.jpg | GRAPHIC | 174401
21 | GRAPHIC | ex99-2_014.jpg | GRAPHIC | 154790
22 | GRAPHIC | ex99-2_015.jpg | GRAPHIC | 146402
23 | GRAPHIC | ex99-2_016.jpg | GRAPHIC | 110392
24 | GRAPHIC | ex99-2_017.jpg | GRAPHIC | 108525
25 | GRAPHIC | ex99-2_018.jpg | GRAPHIC | 114919
26 | GRAPHIC | ex99-2_019.jpg | GRAPHIC | 133402
27 | GRAPHIC | ex99-2_020.jpg | GRAPHIC | 53448
| Complete submission text file | 0001213900-22-023584.txt |  | 4205376

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL SCHEMA FILE | ltrn-20220503.xsd | EX-101.SCH | 3048
5 | XBRL LABEL FILE | ltrn-20220503_lab.xml | EX-101.LAB | 34476
6 | XBRL PRESENTATION FILE | ltrn-20220503_pre.xml | EX-101.PRE | 22605
29 | EXTRACTED XBRL INSTANCE DOCUMENT | ea159290-8k_lantern_htm.xml | XML | 3701

Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39318 | Film No.: 22886714
SIC: 2834 Pharmaceutical Preparations